Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LIPE | Q05469 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8370605 | 0.76 | HIF1A (0.50) | MRGPRX4SCN9ACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL8370602 | 0.76 | HIF1A (0.50) | MRGPRX4SCN9ACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL7537180 | 0.75 | KMT2A (0.41) | RAB9ASMN1; SMN2ALDH1A1KDM4EPOLB | |
| SCHEMBL6961936 | 0.75 | CYP1A2 (0.41) | MRGPRX4SCN9ACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL7542538 | 0.74 | KMT2A (0.41) | HIF1ARAB9ASMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL7535896 | 0.74 | MAPT (0.40) | LMNARAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL31568518 | 0.74 | MRGPRX4 (0.67) | MRGPRX4CYP1A2CYP3A4CYP2C19LMNA | |
| SCHEMBL7536125 | 0.73 | HTT (0.39) | MRGPRX4HIF1ALMNARAB9AALDH1A1 | |
| SCHEMBL7537476 | 0.72 | PPARG (0.36) | HIF1ALMNARAB9ASMN1; SMN2PPARG | |
| SCHEMBL6743790 | 0.68 | MRGPRX4 (0.71) | MRGPRX4CYP1A2CYP3A4CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6362212-B1 | POTENT FUNGICIDAL ACTIVITY | SHIONOGI & COMPANY, LTD. (JP) | 2002-03-26 | — | — | US | disclosed |
| US-20020032227-A1 | Oxime derivative and bactericide containing the same as active ingredient | TAKASE AKIRA (JP) | 2002-03-14 | — | — | US | disclosed |
| US-6268312-B1 | FUNGICIDES | SHIONOGI & CO., LTD. (JP) | 2001-07-31 | — | — | US | disclosed |
| US-6048885-A | FUNGICIDES | SHIONOGI & CO., LTD. (JP) | 2000-04-11 | — | — | US | disclosed |
| EP-0754684-A1 | OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | SHIONOGI & CO., LTD. (JP) | 1997-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032227-A1 | Oxime derivative and bactericide containing the same as active ingredient | MSMO1, O60361, CBR1 | MRGPRX4 3876/4885SCN9A 203/4885CYP1A2 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.